Multivesicular Liposomes: Physicochemical characterization & in vitro drug release testing (12of39)

Soumyarwit Manna from the Office of Generic Drugs provides an introduction to complex formulations. Manna discusses current bioequivalence guidance on bupivacaine-multivesicular liposome (BPV-MVL) and FDA internal research to include physicochemical characterization of BPV-MVL and in vitro drug release study on BPV-MVL.

-----------------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2018 Playlist:    • 2018 CDER Small Business and Industry...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367